These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24295418)

  • 1. Mammalian target of rapamycin inhibitor-associated stomatitis.
    Boers-Doets CB; Raber-Durlacher JE; Treister NS; Epstein JB; Arends AB; Wiersma DR; Lalla RV; Logan RM; van Erp NP; Gelderblom H
    Future Oncol; 2013 Dec; 9(12):1883-92. PubMed ID: 24295418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients.
    Sonis S; Treister N; Chawla S; Demetri G; Haluska F
    Cancer; 2010 Jan; 116(1):210-5. PubMed ID: 19862817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing stomatitis in patients treated with Mammalian target of rapamycin inhibitors.
    Pilotte AP; Hohos MB; Polson KM; Huftalen TM; Treister N
    Clin J Oncol Nurs; 2011 Oct; 15(5):E83-9. PubMed ID: 21951751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous and mucosal aphthosis during temsirolimus therapy for advanced renal cell carcinoma: review of cutaneous and mucosal side effects of mTOR inhibitors.
    De Masson A; Fouchard N; Méry-Bossard L; Dauendorffer JN
    Dermatology; 2011; 223(1):4-8. PubMed ID: 21846963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of oral toxicity associated with mTOR inhibitor therapy in cancer patients.
    Martins F; de Oliveira MA; Wang Q; Sonis S; Gallottini M; George S; Treister N
    Oral Oncol; 2013 Apr; 49(4):293-8. PubMed ID: 23312237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stomatitis associated with mammalian target of rapamycin inhibition: A review of pathogenesis, prevention, treatment, and clinical implications for oral practice in metastatic breast cancer.
    Chambers MS; Rugo HS; Litton JK; Meiller TF
    J Am Dent Assoc; 2018 Apr; 149(4):291-298. PubMed ID: 29439772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical presentation and management of mTOR inhibitor-associated stomatitis.
    de Oliveira MA; Martins E Martins F; Wang Q; Sonis S; Demetri G; George S; Butrynski J; Treister NS
    Oral Oncol; 2011 Oct; 47(10):998-1003. PubMed ID: 21890398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian target of rapamycin inhibitor-associated stomatitis in hematopoietic stem cell transplantation patients receiving sirolimus prophylaxis for graft-versus-host disease.
    Villa A; Aboalela A; Luskin KA; Cutler CS; Sonis ST; Woo SB; Peterson DE; Treister NS
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):503-8. PubMed ID: 25482865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice.
    Peterson DE; O'Shaughnessy JA; Rugo HS; Elad S; Schubert MM; Viet CT; Campbell-Baird C; Hronek J; Seery V; Divers J; Glaspy J; Schmidt BL; Meiller TF
    Cancer Med; 2016 Aug; 5(8):1897-907. PubMed ID: 27334013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common occurrence of everolimus-associated aphthous stomatitis in Japanese heart transplant recipients.
    Sasaoka T; Kato TS; Oda N; Wada K; Komamura K; Asakura M; Hashimura K; Ishibashi-Ueda H; Nakatani T; Isobe M; Kitakaze M
    Transplant Proc; 2010 Nov; 42(9):3700-3. PubMed ID: 21094841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toxicity management for mTOR inhibitors].
    Mukohara T
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():272-6. PubMed ID: 25831766
    [No Abstract]   [Full Text] [Related]  

  • 12. mTOR inhibitor-associated dermatologic and mucosal problems.
    Campistol JM; de Fijter JW; Flechner SM; Langone A; Morelon E; Stockfleth E
    Clin Transplant; 2010; 24(2):149-56. PubMed ID: 20236129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral adverse events associated with tyrosine kinase and mammalian target of rapamycin inhibitors in renal cell carcinoma: a structured literature review.
    Boers-Doets CB; Epstein JB; Raber-Durlacher JE; Ouwerkerk J; Logan RM; Brakenhoff JA; Lacouture ME; Gelderblom H
    Oncologist; 2012; 17(1):135-44. PubMed ID: 22207567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adverse cutaneous effects and quality of life in patients treated with mTOR inhibitors for renal carcinoma].
    Voilliot-Trotot C; Granel-Brocard F; Geoffrois L; Tréchot P; Nguyen-Thi P; Schmutz JL; Barbaud A
    Ann Dermatol Venereol; 2013 May; 140(5):353-62. PubMed ID: 23663707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral toxicity of targeted anticancer therapies].
    Sibaud V; Boralevi F; Vigarios E; Fricain JC
    Ann Dermatol Venereol; 2014 May; 141(5):354-63. PubMed ID: 24835648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral stomatitis and mTOR inhibitors: A review of current evidence in 20,915 patients.
    Lo Muzio L; Arena C; Troiano G; Villa A
    Oral Dis; 2018 Mar; 24(1-2):144-171. PubMed ID: 29480626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors.
    Vigarios E; Epstein JB; Sibaud V
    Support Care Cancer; 2017 May; 25(5):1713-1739. PubMed ID: 28224235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events associated with mTOR inhibitors.
    Pallet N; Legendre C
    Expert Opin Drug Saf; 2013 Mar; 12(2):177-86. PubMed ID: 23252795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onychopathy induced by temsirolimus, a mammalian target of rapamycin inhibitor.
    Peuvrel L; Quéreux G; Brocard A; Saint-Jean M; Dréno B
    Dermatology; 2012; 224(3):204-8. PubMed ID: 22614575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral ulcers in patients with advanced breast cancer receiving everolimus: a case series report on clinical presentation and management.
    Nicolatou-Galitis O; Nikolaidi A; Athanassiadis I; Papadopoulou E; Sonis S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):e110-6. PubMed ID: 23643584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.